Lewicki John A. — SEC Form 4 filings
SEC reporting owner CIK 1553352. 7 Form 4 filings on record with FilingPulse; latest filed 2026-02-02.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-01-26 to 2026-02-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 2 filings — 40,373 shares, $153,904 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 16,808 shares @ $3.39 ($57,033) in Mereo BioPharma Group plc, filed 2024-06-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Mereo BioPharma Group plc (MREO) | Chief Scientific Officer | 7 | — | 4 legs · 40,373 sh · $153,904 | 9 |
Form 4 filings — Lewicki John A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-02 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 139,913 (derivative) @ $0 · Grant/award (A): 46,637 (derivative) @ $0 · Grant/award (A): 145,000 (derivative) @ $0 | EDGAR |
| 2025-01-28 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 116,000 (derivative) @ $0 | EDGAR |
| 2024-09-16 | 4 | Mereo BioPharma Group plc (MREO) | Sale (S): 5,212 @ $4.47 · Sale (S): 10,937 @ $4.22 | EDGAR |
| 2024-09-13 | 4 | Mereo BioPharma Group plc (MREO) | Option exercise (M): 46,000 @ $0 · Option exercise (M): 46,000 (derivative) @ $0 | EDGAR |
| 2024-06-27 | 4 | Mereo BioPharma Group plc (MREO) | Sale (S): 7,416 @ $3.69 · Sale (S): 16,808 @ $3.39 | EDGAR |
| 2024-06-25 | 4 | Mereo BioPharma Group plc (MREO) | Option exercise (M): 69,000 @ $0 · Option exercise (M): 69,000 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | Mereo BioPharma Group plc (MREO) | Grant/award (A): 137,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1553352 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →